What is Novo Nordisk known for?

Novo Nordisk is a global pharmaceutical company with a focus on serious chronic diseases, particularly diabetes and obesity. Its portfolio includes several medicines for diabetes care and other health conditions.

What is the difference between Rybelsus 3 mg, 7 mg and 14 mg?

The products contain different strengths of semaglutide. Their roles depend on the approved treatment instructions and the patient's prescription. They should not be substituted for one another without medical guidance.

Does Rybelsus contain semaglutide?

Yes. Semaglutide is the active ingredient in Rybelsus tablets.

Is Rybelsus the same as injectable semaglutide?

No. Rybelsus is an oral tablet formulation, while other semaglutide brands are available as injections. Their instructions, formulations and approved uses can differ, so they should not be substituted without guidance from a healthcare professional.

Is Rybelsus a weight-loss medicine?

Rybelsus is used for type 2 diabetes management under its approved product information. Weight changes may occur during treatment, but Rybelsus should not automatically be considered equivalent to semaglutide products specifically authorised for weight management.

Novo Nordisk Products | Rybelsus 3 mg, 7 mg & 14 mg

About Novo Nordisk

Novo Nordisk is a global pharmaceutical company founded in Denmark in 1923. The company focuses on developing treatments for serious chronic diseases, with a strong emphasis on diabetes, obesity and other long-term health conditions. Through scientific research and pharmaceutical innovation, Novo Nordisk develops medicines intended to support patients and healthcare professionals in managing these conditions.

One of its recognised diabetes medicine brands is Rybelsus, which contains semaglutide. Unlike semaglutide injections, Rybelsus is an oral tablet formulation. It belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist class and is used for the management of type 2 diabetes according to the applicable product information.

At KwickPharmacy, customers can explore available Novo Nordisk products by brand name, active ingredient and strength. Reviewing the product details helps users understand what each medicine contains and identify the information they should confirm with a healthcare professional.

Popular Novo Nordisk Medicines

Rybelsus – Semaglutide Tablets

Rybelsus contains semaglutide, a GLP-1 receptor agonist used to improve blood glucose control in adults with type 2 diabetes when prescribed appropriately. It works by activating GLP-1 receptors, helping the body regulate blood glucose in response to meals and influencing appetite.

The Novo Nordisk products listed in the supplied catalogue include:

Rybelsus 3 mg – Semaglutide 3 mg
Rybelsus 7 mg – Semaglutide 7 mg
Rybelsus 14 mg – Semaglutide 14 mg

These strengths have different roles in treatment and should not be considered interchangeable. The appropriate product and treatment plan depend on the prescription, local product information and individual medical circumstances.

Understanding Semaglutide

Semaglutide is a GLP-1 receptor agonist that helps regulate blood glucose and can affect appetite. Rybelsus is an oral formulation developed for type 2 diabetes management. Its instructions for use are specific to the product because food, drinks and other oral medicines can affect how much semaglutide the body absorbs.

Although semaglutide is also used in certain weight-management medicines, the approved use depends on the specific brand, formulation and country. Rybelsus should not automatically be treated as interchangeable with semaglutide products approved for weight management.

Rybelsus 3 mg, 7 mg and 14 mg: What Is the Difference?

Rybelsus is available in multiple strengths to support a clinician-directed treatment plan. The 3 mg strength is used as an introductory strength in some approved product instructions, while 7 mg and 14 mg strengths may be used according to the relevant prescribing guidance.

The strengths are not intended for patients to select or change independently. A healthcare professional determines the appropriate treatment based on blood glucose control, tolerance, other medicines and individual health needs. Always follow the instructions supplied with the specific product available in your country.

Safety Information for Rybelsus

Rybelsus can cause side effects, including nausea, diarrhoea, vomiting, constipation and abdominal discomfort. More serious problems, including pancreatitis and gallbladder complications, have also been reported. Semaglutide products have important contraindications and warnings that must be reviewed before treatment.

Tell your healthcare professional about your medical history, existing medicines and any previous reactions to semaglutide. People with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should discuss the relevant product contraindications with their clinician, as these apply to certain Rybelsus labels.

Do not start, stop or adjust treatment without professional guidance. The medicine's prescribing information and patient leaflet should be checked for the exact formulation and market.

How to Choose the Right Novo Nordisk Medicine

When reviewing a Novo Nordisk product, check the brand name, active ingredient, strength, dosage form and instructions on the packaging. Rybelsus is an oral semaglutide tablet, and its administration requirements differ from those of injectable semaglutide products.

For diabetes treatment, a healthcare professional considers blood glucose levels, medical history, other medicines and treatment goals. Do not use a medicine prescribed for someone else or change strengths based on online information alone.

Purchase medicines through legitimate channels and follow applicable prescription requirements. Keep the product packaging and patient information leaflet so the exact medicine can be verified.

Novo Nordisk